Clinical effects of adding tolvaptan to intravenous furosemide in patients with congestive heart failure
Background: Tolvaptan, a vasopressin V2 receptor antagonist, is a strong diuretic with a new mechanism of action and has good adaptation to patients with congestive heart failure. Knowledge on the proper use of furosemide, an existing therapeutic drug, is not yet sufficient. Objectives: Clinical dif...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Series: | Research in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2017;volume=6;issue=4;spage=14;epage=19;aulast=Kato |